Teacher Retirement System of Texas reduced its stake in shares of Liquidia Technologies, Inc. (NASDAQ:LQDA – Free Report) by 16.0% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 13,707 shares of the company’s stock after selling 2,615 shares during the quarter. Teacher Retirement System of Texas’ holdings in Liquidia Technologies were worth $202,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Corebridge Financial Inc. lifted its holdings in Liquidia Technologies by 2.3% in the 4th quarter. Corebridge Financial Inc. now owns 31,516 shares of the company’s stock valued at $371,000 after acquiring an additional 694 shares during the last quarter. GAMMA Investing LLC raised its holdings in Liquidia Technologies by 65.6% during the 1st quarter. GAMMA Investing LLC now owns 2,961 shares of the company’s stock worth $44,000 after buying an additional 1,173 shares during the period. Cetera Investment Advisers raised its holdings in Liquidia Technologies by 4.3% during the 4th quarter. Cetera Investment Advisers now owns 31,243 shares of the company’s stock worth $367,000 after buying an additional 1,277 shares during the period. Valmark Advisers Inc. raised its holdings in Liquidia Technologies by 7.4% during the 1st quarter. Valmark Advisers Inc. now owns 18,641 shares of the company’s stock worth $275,000 after buying an additional 1,283 shares during the period. Finally, Summit Investment Advisors Inc. raised its holdings in Liquidia Technologies by 35.0% during the 4th quarter. Summit Investment Advisors Inc. now owns 6,632 shares of the company’s stock worth $78,000 after buying an additional 1,719 shares during the period. 64.54% of the stock is currently owned by institutional investors.
Insider Activity
In other Liquidia Technologies news, insider Sarah Krepp sold 2,673 shares of the company’s stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total transaction of $38,170.44. Following the completion of the sale, the insider owned 142,499 shares of the company’s stock, valued at $2,034,885.72. This represents a 1.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Scott Moomaw sold 4,797 shares of the company’s stock in a transaction that occurred on Monday, July 14th. The stock was sold at an average price of $14.28, for a total value of $68,501.16. Following the sale, the insider directly owned 223,231 shares of the company’s stock, valued at $3,187,738.68. The trade was a 2.10% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 56,689 shares of company stock valued at $809,501. Insiders own 30.10% of the company’s stock.
Liquidia Technologies Trading Down 0.4%
Liquidia Technologies (NASDAQ:LQDA – Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($0.45) EPS for the quarter, missing the consensus estimate of ($0.42) by ($0.03). The firm had revenue of $3.12 million during the quarter, compared to the consensus estimate of $3.23 million. Liquidia Technologies had a negative net margin of 903.80% and a negative return on equity of 177.91%. On average, research analysts predict that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on LQDA. Scotiabank boosted their price objective on Liquidia Technologies from $36.00 to $37.00 and gave the stock a “sector outperform” rating in a report on Wednesday, May 28th. BTIG Research restated a “buy” rating on shares of Liquidia Technologies in a report on Tuesday, May 27th. Wall Street Zen upgraded Liquidia Technologies from a “sell” rating to a “hold” rating in a report on Thursday, May 22nd. Wells Fargo & Company upped their target price on Liquidia Technologies from $23.00 to $25.00 and gave the company an “overweight” rating in a report on Thursday, June 12th. Finally, HC Wainwright upped their target price on Liquidia Technologies from $29.00 to $35.00 and gave the company a “buy” rating in a report on Wednesday, May 28th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $26.89.
View Our Latest Analysis on LQDA
About Liquidia Technologies
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Further Reading
- Five stocks we like better than Liquidia Technologies
- CD Calculator: Certificate of Deposit Calculator
- 3 Streaming Stocks to Watch as Subscribers Drive Growth
- What is the Nikkei 225 index?
- America Wants Drone Dominance: Are These Stocks Ready to Soar?
- How to Short a Stock in 5 Easy Steps
- 3 Retailers Poised to Outmaneuver Tariff and Recession Concerns
Want to see what other hedge funds are holding LQDA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Liquidia Technologies, Inc. (NASDAQ:LQDA – Free Report).
Receive News & Ratings for Liquidia Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia Technologies and related companies with MarketBeat.com's FREE daily email newsletter.